Sonelokimab

Drug identity checked against registry records

Also recorded as M1095

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugNCT06641076MoonLake Immunotherapeutics AGPhase 3Active not recruiting2026-05-28Actual
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseNCT06641089MoonLake Immunotherapeutics AGPhase 3Active not recruiting2027-01-04Estimated
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411379MoonLake Immunotherapeutics AGPhase 3Completed2025-08-14Actual
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis SuppurativaNCT07007637MoonLake Immunotherapeutics AGPhase 3Enrolling by invitation2028-06-13Estimated
An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)NCT06768671MoonLake Immunotherapeutics AGPhase 3Completed2026-09-28Actual
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic ArthritisNCT07223138MoonLake Immunotherapeutics AGPhase 3Enrolling by invitation2028-02-04Estimated
A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411899MoonLake Immunotherapeutics AGPhase 3Completed2025-09-02Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisNCT05640245MoonLake Immunotherapeutics AGPhase 2Completed2023-09-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.